Man Group PLC Siga Technologies Inc Transaction History

Man Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.32 - $5.77 $156,345 - $208,822	36,191 New	36,191 $190,000
Q4 2022 Feb 14, 2023	BUY	$7.29 - $10.14 $179,734 - $250,001	24,655 New	24,655 $181,000
Q2 2022 Aug 15, 2022	SELL	$6.5 - $13.68 $340,522 - $716,667	-52,388 Reduced 62.18%	31,865 $369,000
Q1 2022 May 16, 2022	SELL	$5.96 - $7.61 $24,716 - $31,558	-4,147 Reduced 4.69%	84,253 $597,000
Q4 2021 Feb 14, 2022	BUY	$6.96 - $9.26 $330,600 - $439,850	47,500 Added 116.14%	88,400 $665,000
Q3 2021 Nov 15, 2021	BUY	$5.71 - $7.39 $233,539 - $302,251	40,900 New	40,900 $302,000

184

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $434M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.